Development

Editor of Pharmaceutical Technology Europe

Articles

The right partner can help companies overcome key formulation challenges for biologic drugs.

Overcoming Biologic Drug Formulation Hurdles

A newly developed polymer, DynaShield, may have the capability to ensure global access for COVID-19 treatment and prevention.

Helena Offers Polymer Solution to Global Cold Chain Issues for COVID-19 Vaccines, Biologics, and Therapeutics

Evonik offers lipid nanoparticles for gene-based drug development and manufacturing. 

Evonik Supplies Key LNP Technology for Gene-Based Drugs

A development agreement will study inhaled formulations of cannabinoid-based drug product for central nervous system diseases.

Kindeva and BOL Pharma to Develop Inhaled Cannabinoid Products

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Operator, caregiver, and patient safety are at the forefront when selecting the best options and dosage forms.

HPAPI Complexity Prompts New Delivery Mechanisms

Supriya Bhide is a graduate student at the Department of Pharmaceutics and Drug Delivery, University of Mississippi, MS.

Apoorva Panda is a graduate student at the Department of Pharmaceutics and Drug Delivery, University of Mississippi, MS.

S. Rangappa is a research scientist at the Department of Pharmaceutics and Drug Delivery, University of Mississippi, MS.

Abhishek Shettar is a research scientist at the Department of Pharmaceutics and Drug Delivery, University of Mississippi, MS.

M.A. Repka is professor and chair at the Department of Pharmaceutics and Drug Delivery, University of Mississippi, MS.

Rosa Maria Badani Prado is a graduate student at the Dave C. Swalm School of Chemical Engineering, Mississippi State University, MS.

S. Kundu is associate professor at the Dave C. Swalm School of Chemical Engineering, Mississippi State University, MS.

Norman Richardson is technical sales manager at BASF Pharma Solutions, Florham Park, NJ.

S. Narasimha Murthy is professor of Pharmaceutics and Drug Delivery at the University of Mississippi, MS, founder-director of the Institute for Drug Delivery and Biomedical Research, Bangalore, Karnataka, India, and chief scientific officer, Topical Products Testing LLC, University, MS.

Study results indicate that fatty alcohols may plausibly enhance the skin permeation of clotrimazole.

Evaluating the Impact of Fatty Alcohols on Permeation of Clotrimazole from Topical Creams

At the 2020 Bio/Pharma Virtual Congress, experts discuss the importance of characterizing excipients to ensure quality, safety, and effective performance. 

Understanding Excipient Quality and Impact on Formulation

Nasser Nyamweya, PhD*, nasser04@yahoo.com, is a Director at Pharma Manufacturing Solutions. He was previously a Lecturer at the School of Pharmacy, University of Nairobi.

Samantha Kimani is a Pharmacist (B.Pharm) and recently graduated from the University of Nairobi.



This paper reviews considerations for the formulation of chewable tablets including sensory characteristics, chewability assessment, and drug release.

Chewable Tablets: A Review of Formulation Considerations

Amorphous solid dispersions are a useful tool in overcoming solubility issues, but they have not yet reached full potential in commercial success.

Improving Solubility with Amorphous Solid Dispersions

The IQ Consortium marks a decade of impactful innovation of collaboration through a network of pharmaceutical companies driving change for the bio/pharmaceutical industry.  